Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...
The host of the hit Huberman Lab podcast is monitoring his light levels, tracking his micronutrients, and drinking in ...
Your urine can tell you a lot about your reproductive health hormones. Unfortunately, at-home testing can be cumbersome, ...
The newest LG flagship OLED TV is less than 0.4 inches thick, and gets video from a wireless box you can place up to 30 feet ...
Samantha Milton, known as "Smaller Sam PCOS" on social media, reached 400 lbs. at her heaviest and decided to lose weight ...
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...
Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on ...
Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...
New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. Dexcom, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback